Institutional Ownership
Marker Therapeutics Inc
CUSIP 57055L206COM NEWMRKRQ1 2026
13D / 13G Filings
9
Schedule 13D/13G on record
Beneficial Filers
4
Distinct reporting persons
Largest Stake
15.2%
Max % of class reported
Institutional Holders
33
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
9 filings · latest Nov 17, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Nov 17, 2025 | New Enterprise Associates 16, L.P. | 13D/A | 9.9% | — | SEC |
| 2 | Nov 14, 2025 | Alyeska Investment Group, L.P. | 13G/A | 9.9% | 1.28M | SEC |
| 3 | Aug 18, 2025 | New Enterprise Associates 16, L.P. | 13D/A | 12.6% | — | SEC |
| 4 | May 15, 2025 | Blue Owl Capital Holdings LP | 13G/A | 11.0% | 1.13M | SEC |
| 5 | Feb 14, 2025 | Alyeska Investment Group, L.P. | 13G | 10.0% | 1.07M | SEC |
| 6 | Feb 14, 2025 | Blue Owl Capital Holdings LP | 13G | 11.0% | 554.3K | SEC |
| 7 | Dec 23, 2024 | New Enterprise Associates 16, L.P. | 13D/A | 15.2% | — | SEC |
| 8 | May 17, 2024 | New Enterprise Associates 16, L.P. | 13D/A | 12.0% | 1.07M | SEC |
| 9 | Mar 3, 2023 | Aisling Capital IV, LP | 13D/A | 5.5% | 464.3K | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Nea Management Company, LLC | 1.63M | $2.11M |
| 2 | Blue Owl Capital Holdings LP | 554.3K | $720.5K |
| 3 | Aisling Capital Management LP | 325.4K | $423.0K |
| 4 | Renaissance Technologies LLC | 175.3K | $227.9K |
| 5 | Geode Capital Management, LLC | 160.9K | $209.2K |
| 6 | Osaic Holdings, Inc. | 93.1K | $121.1K |
| 7 | Lpl Financial LLC | 83.0K | $108.0K |
| 8 | Xtx Topco Ltd | 63.6K | $82.6K |
| 9 | Two Sigma Investments, LP | 61.0K | $79.3K |
| 10 | Susquehanna International Group, LLP | 48.8K | $63.4K |